Structure, function, and disease biology of MICU1/MICU2
MICU1/MICU2的结构、功能和疾病生物学
基本信息
- 批准号:9980297
- 负责人:
- 金额:$ 46.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAllelesAnimalsBindingBioenergeticsBiologyBiophysicsCalciumCalcium BindingCalcium ChannelCalcium SignalingCalcium-Binding ProteinsCell LineCellsClinicalCommunicationComplexCryoelectron MicroscopyDataDefectDiseaseEF Hand MotifsElectronsElectrophysiology (science)Energy MetabolismEngineeringEnzymesEscherichia coliExerciseFatigueFiberGeneticGenomicsGoalsGrantHistocytochemistryHistologyHomeostasisHomologous GeneHumanHuman GenomeInheritedIon ChannelKineticsKnock-outKnockout MiceLeadLengthLesionMeasuresMembrane PotentialsMetabolicMitochondriaMitochondrial MyopathiesModelingMolecularMusMuscleMuscle ContractionMuscle FatigueMuscle WeaknessMutationMyopathyNADHNamesNeurologicOrganellesOxygen ConsumptionPatientsPerformancePeripheralPhysiologyPlasmaPositioning AttributeProcessProductionPropertyProteinsRegulationReportingResolutionRestRoentgen RaysRoleSignal TransductionSkeletal MuscleStrenuous ExerciseStructural ModelsStructureSystemTechnologyTestingTissuesWorkX-Ray Crystallographycommon symptomdesignexercise intolerancegenome editingin vivoloss of function mutationmetabolic profilemetabolomicsmouse modelmutantnervous system disorderneurotransmissionresponseuptake
项目摘要
ABSTRACT
Mitochondria uptake calcium via a calcium activated channel called the uniporter. Calcium uptake allows the
organelle's metabolic state to be matched to rapidly changing energy requirements, and, in turn, tune
key processes such as neurotransmission and muscle contraction. The uniporter is calcium-activated calcium
channel regulated by the calcium binding heterodimer MICU1/MICU2. Mutations in MICU1 have recently been
identified as a cause of a new form of a myopathy characterized by fatigue and exercise intolerance without
the classical features of mitochondrial myopathy. The precise mechanisms by which MICU1 and MICU2 sense
calcium to regulate the uniporter, and how lesions in this heterodimer lead to this highly unusual myopathy are
not known. Through this dual PI grant we propose to: (1) Characterize the physicochemical properties of
MICU1 and MICU2. The wild type proteins and mutants expressed in E. coli will be characterized with respect
to the oligomeric state, structural stability, Ca2+ and Mg2+ binding affinities, and pH sensitivity. (2) Determine the
structural basis for the regulation of the uniporter by MICU1 and MICU2. High resolution X-ray structures of
MICU2 alone and of the MICU1/2 heterodimer in the apo and Ca2+-bound forms will be determined.
Electron cryo-microscopy will be used to determine the structure of a native-like oligomer of MICU1/2
complex. (3) Investigate mitochondrial calcium dynamics in cellular systems. Using genome-editing technology
we have engineered a powerful in vivo system of knockout cell lines for studying the effects of engineered and
naturally occurring human mutations in MICU1 and MICU2 on the mitochondrial calcium transport kinetics and
energetics, and (4) Understand the metabolic and bioenergetic basis of human MICU1 myopathy by
investigating the Micu1-/- mouse as a model. We will characterize the muscle histology, mitochondrial
bioenergetics, exercise performance and metabolomics, and single fiber contractility to test the hypothesis that
loss of MICU1 leads to a myopathy by causing disturbances in energy metabolism. Our aims – spanning the
molecular to animal physiology -- will yield a holistic and mechanistic understanding of the regulation
of mitochondrial calcium uptake by MICU1 and MICU2 and its contribution to a newly described human
myopathy.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zenon Grabarek其他文献
Zenon Grabarek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zenon Grabarek', 18)}}的其他基金
Structure, function, and disease biology of MICU1/MICU2
MICU1/MICU2的结构、功能和疾病生物学
- 批准号:
10197754 - 财政年份:2018
- 资助金额:
$ 46.43万 - 项目类别:
Structure, function, and disease biology of MICU1/MICU2
MICU1/MICU2的结构、功能和疾病生物学
- 批准号:
10450735 - 财政年份:2018
- 资助金额:
$ 46.43万 - 项目类别:
Structure, function, and disease biology of MICU1/MICU2
MICU1/MICU2的结构、功能和疾病生物学
- 批准号:
9768959 - 财政年份:2018
- 资助金额:
$ 46.43万 - 项目类别:
Troponin and myosin in regulation of muscle contraction and heart disease
肌钙蛋白和肌球蛋白调节肌肉收缩和心脏病
- 批准号:
8197235 - 财政年份:2008
- 资助金额:
$ 46.43万 - 项目类别:
Troponin and myosin in regulation of muscle contraction and heart disease
肌钙蛋白和肌球蛋白调节肌肉收缩和心脏病
- 批准号:
7746421 - 财政年份:2008
- 资助金额:
$ 46.43万 - 项目类别:
Troponin and myosin in regulation of muscle contraction and heart disease
肌钙蛋白和肌球蛋白调节肌肉收缩和心脏病
- 批准号:
7584532 - 财政年份:2008
- 资助金额:
$ 46.43万 - 项目类别:
Troponin and myosin in regulation of muscle contraction and heart disease
肌钙蛋白和肌球蛋白调节肌肉收缩和心脏病
- 批准号:
7994840 - 财政年份:2008
- 资助金额:
$ 46.43万 - 项目类别:
MYOSIN PHOSPHORYLATION BY MYOSIN LIGHT CHAIN KINASE
肌球蛋白轻链激酶磷酸化肌球蛋白
- 批准号:
6434896 - 财政年份:2001
- 资助金额:
$ 46.43万 - 项目类别:
MYOSIN PHOSPHORYLATION BY MYOSIN LIGHT CHAIN KINASE
肌球蛋白轻链激酶磷酸化肌球蛋白
- 批准号:
6571145 - 财政年份:2001
- 资助金额:
$ 46.43万 - 项目类别:
MYOSIN PHOSPHORYLATION BY MYOSIN LIGHT CHAIN KINASE
肌球蛋白轻链激酶磷酸化肌球蛋白
- 批准号:
6570926 - 财政年份:2001
- 资助金额:
$ 46.43万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 46.43万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 46.43万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 46.43万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 46.43万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 46.43万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 46.43万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 46.43万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 46.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 46.43万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 46.43万 - 项目类别:














{{item.name}}会员




